115370 Results

People

  1. Ladanyi
    Ladanyi
  2. Motzer
    Motzer
  3. Reuter
    Reuter
  4. Scher
    Scher
  5. Brennan
    Brennan
  6. Giralt
    Giralt
  7. Gonen
    Gonen
  8. Perales
    Perales
  9. Hudis
    Hudis
  10. Jarnagin
    Jarnagin

Groups

  1. Department of Medicine (39033)
  2. GSK Faculty (22468)
  3. Solid Tumor Oncology Division (22056)
  4. Surgery (21247)
  5. Sloan Kettering Institute Faculty (16086)
  6. Survivorship Research (15762)
  7. Center for Hematologic Malignancies (13263)
  8. Hematologic Malignancies, Division of (13087)
  9. Sloan Kettering Institute Postdocs (12936)
  10. Department of Pathology and Laboratory Medicine (12615)
Formats
  1. Journal Article (66746)
  2. Meeting Abstract (33620)
  3. Book Section (5027)
  4. Review (3744)
  5. Editorial (2162)
  6. Conference Paper (1525)
  7. Correspondence (661)
  8. Guidelines (660)
  9. Research Letter (548)
  10. Miscellaneous (339)
  11. Book Whole (338)
Groups
  1. Department of Medicine (39033)
  2. GSK Faculty (22468)
  3. Solid Tumor Oncology Division (22056)
  4. Surgery (21247)
  5. Sloan Kettering Institute Faculty (16086)
  6. Survivorship Research (15762)

More Groups

People
  1. Marc Ladanyi (1327)
  2. Robert Motzer (1243)
  3. Victor Reuter (1228)
  4. Howard Scher (1130)
  5. Murray Brennan (1059)
  6. Sergio Giralt (1050)

More People

Years
  1. 2025 (1982)
  2. 2024 (5377)
  3. 2023 (5804)
  4. 2022 (6168)
  5. 2021 (5712)
  6. 2020 (5598)

More Years

Publications
  1. Journal of Clinical Oncology (8590)
  2. Blood (4950)
  3. Cancer Research (2701)
  4. International Journal of Radiation Oncology, Biology, Physics (2610)
  5. Laboratory Investigation (1879)
  6. Modern Pathology (1812)

More Publications

Publishers
  1. Elsevier Inc. (13855)
  2. American Society of Clinical Oncology (9157)
  3. Springer (7152)
  4. Nature Publishing Group (6367)
  5. American Association for Cancer Research (6002)
  6. Elsevier Science, Inc. (5503)

More Publishers

Results (115370)


Citation style sort is year ascending, and then by author or title. Author ascending is default.
  • Lobar or sub-lobar resection for peripheral clinical stage IA = 2 cm non-small cell lung Cancer (NSCLC): Results from an international randomized phase III trial (CALGB 140503 [Alliance])
    Meeting Abstract

    Altorki, N. K.; Wang, X.; Kozono, D.; Watt, C.; Landreneau, R.; Wigle, D.; Port, J.; Jones, D. R.; Conti, M.; Ashrafi, A. S.; more...
    Journal of Thoracic Oncology (2022)

    Fulltext@MSK | Save
  • Shared decision making in patients with breast and gynecologic malignancies receiving chemotherapy regimens associated with persistent alopecia
    Meeting Abstract

    Freites-Martinez, A.; O'Cearbhaill, R. E.; Friedman, C. F.
    Journal of the American Academy of Dermatology (2022)

    Fulltext@MSK | Save
  • Autoantibody profiles of bullous immune-related cutaneous adverse events from immune checkpoint blockade may present with atypical or typical antibody serologies
    Meeting Abstract

    Kuo, A. M.; Kraehenbuehl, L.; Haliasos, H. C.
    Journal of the American Academy of Dermatology (2022)

    Fulltext@MSK | Save
  • Six-year results from RELEVANCE: Lenalidomide plus rituximab (R(2)) versus rituximab-chemotherapy followed by rituximab maintenance in untreated advanced follicular lymphoma
    Journal Article

    Morschhauser, F.; Nastoupil, L.; Feugier, P.; Schiano de Colella, J. M.; Tilly, H.; Palomba, M. L.; Bachy, E.; Fruchart, C.; Libby, E. N.; Casasnovas, R. O.; more...
    Journal of Clinical Oncology (2022)

    Fulltext@MSK | Save
  • Hematologic malignancies: 2022 ASCO Annual Meeting highlights for the advanced practitioner
    Review

    Allred, P. A.; Pierre, A.; Beaton, M.; Lee, P.; Koehler, A.
    Journal of the Advanced Practitioner in Oncology (2022)

    Fulltext@MSK | Save
  • Gastrointestinal cancer: 2022 ASCO Annual Meeting highlights for the advanced practitioner
    Review

    Grenon, N. N.; O'Hagan, K.
    Journal of the Advanced Practitioner in Oncology (2022)

    Fulltext@MSK | Save
  • Efficacy of preoperative mFOLFIRINOX vs mFOLFIRINOX plus hypofractionated radiotherapy for borderline resectable adenocarcinoma of the pancreas: The A021501 phase 2 randomized clinical trial
    Journal Article

    Katz, M. H. G.; Shi, Q.; Meyers, J.; Herman, J. M.; Chuong, M.; Wolpin, B. M.; Ahmad, S.; Marsh, R.; Schwartz, L.; Behr, S.; more...
    JAMA Oncology (2022)

    Fulltext@MSK | Save
  • Association between toxic effects and survival in patients with cancer and autoimmune disease treated with checkpoint inhibitor immunotherapy
    Research Letter

    Han, C. Y.; Fitzgerald, C.; Lee, M.; Valero, C.; Gönen, M.; Shoushtari, A.; Morris, L. G. T.
    JAMA Oncology (2022)

    Fulltext@MSK | Save
  • Brain metastasis—A distinct oncologic disease best served by an integrated multidisciplinary team approach
    Editorial

    Moss, N. S.; Beal, K.; Tabar, V.
    JAMA Oncology (2022)

    Fulltext@MSK | Save
  • Long-term results of a multi-institutional phase II study of hypofractionated proton beam irradiation of unresectable primary liver tumors
    Meeting Abstract

    Roberts, H. J.; Hong, T. S.; Ly, L.; Yeap, B. Y.; Ben-Josef, E.; Zhu, A. X.; Goyal, L.; Franses, J.; Ryan, D. P.; Allen, J. N.; more...
    International Journal of Radiation Oncology, Biology, Physics (2022)

    Fulltext@MSK | Save